Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01HGT
|
||||
| Former ID |
DCL001142
|
||||
| Drug Name |
Anti-CD22
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Hematologic malignancies [ICD9: 200-209; ICD10:C81-C86] | Phase 1 | [551667] | ||
| Company |
Seattle Genetics; Genentech
|
||||
| Target and Pathway | |||||
| Target(s) | B-cell receptor CD22 | Target Info | [551667] | ||
| PANTHER Pathway | B cell activation | ||||
| Pathway Interaction Database | BCR signaling pathway | ||||
| WikiPathways | B Cell Receptor Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.